{"id":"https://openalex.org/W2094566524","doi":"https://doi.org/10.2174/1568015033357779","title":"Glutamate mGlu5-Adenosine A2A-Dopamine D2 Receptor Interactions in the Striatum. Implications for Drug Therapy in Neuro-psychiatric Disorders and Drug Abuse","display_name":"Glutamate mGlu5-Adenosine A2A-Dopamine D2 Receptor Interactions in the Striatum. Implications for Drug Therapy in Neuro-psychiatric Disorders and Drug Abuse","publication_year":2003,"publication_date":"2003-03-01","ids":{"openalex":"https://openalex.org/W2094566524","doi":"https://doi.org/10.2174/1568015033357779","mag":"2094566524"},"language":"en","primary_location":{"id":"doi:10.2174/1568015033357779","doi":"https://doi.org/10.2174/1568015033357779","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1568015033357779","pdf_url":null,"source":{"id":"https://openalex.org/S2765063124","display_name":"Central Nervous System Agents in Medicinal Chemistry","issn_l":"1568-0150","issn":["1568-0150","1871-5249","1875-6158","1875-6166"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry-Central Nervous System Agents","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000524771","display_name":"Sergi Ferr\u00e9","orcid":"https://orcid.org/0000-0002-1747-1779","observed_orcids":["https://orcid.org/0000-0002-1747-1779"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sergi Ferre","raw_affiliation_strings":["National Institutes of Health, UNITED STATES"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institutes of Health, UNITED STATES","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032553363","display_name":"Francisco Ciruela","orcid":"https://orcid.org/0000-0003-0832-3739","observed_orcids":["https://orcid.org/0000-0003-0832-3739"]},"institutions":[{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Francisco Ciruela","raw_affiliation_strings":["Universitat de Barcelona (University of Barcelona)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universitat de Barcelona (University of Barcelona)","institution_ids":["https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069741153","display_name":"Amina S. Woods","orcid":"https://orcid.org/0000-0002-9716-345X","observed_orcids":["https://orcid.org/0000-0002-9716-345X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amina Woods","raw_affiliation_strings":["Chemistry and Drug Metabolism Section"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chemistry and Drug Metabolism Section","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045741606","display_name":"Meritxell Canals","orcid":"https://orcid.org/0000-0002-7942-5006","observed_orcids":["https://orcid.org/0000-0002-7942-5006"]},"institutions":[{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Meritxell Canals","raw_affiliation_strings":["Universitat de Barcelona (University of Barcelona)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universitat de Barcelona (University of Barcelona)","institution_ids":["https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079313086","display_name":"Javier Burgue\u00f1o","orcid":"https://orcid.org/0000-0001-8938-8299","observed_orcids":["https://orcid.org/0000-0001-8938-8299"]},"institutions":[{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Javier Burgueno","raw_affiliation_strings":["Universitat de Barcelona (University of Barcelona)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universitat de Barcelona (University of Barcelona)","institution_ids":["https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001436428","display_name":"Daniel J. Marcellino","orcid":"https://orcid.org/0000-0002-4618-7267","observed_orcids":["https://orcid.org/0000-0002-4618-7267"]},"institutions":[{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Daniel Marcellino","raw_affiliation_strings":["Universitat de Barcelona (University of Barcelona)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universitat de Barcelona (University of Barcelona)","institution_ids":["https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046254424","display_name":"Marzena Karcz\u2010Kubicha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marzena Karcz-Kubicha","raw_affiliation_strings":["Preclinical Pharmacology Section"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Pharmacology Section","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054676202","display_name":"Bruce T. Hope","orcid":"https://orcid.org/0000-0001-5804-7061","observed_orcids":["https://orcid.org/0000-0001-5804-7061"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bruce Hope","raw_affiliation_strings":["Behavioral Neuroscience Section"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Behavioral Neuroscience Section","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052939200","display_name":"Marisela Morales","orcid":"https://orcid.org/0000-0002-3845-9402","observed_orcids":["https://orcid.org/0000-0002-3845-9402"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marisela Morales","raw_affiliation_strings":["National Institutes of Health, UNITED STATES"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Institutes of Health, UNITED STATES","institution_ids":["https://openalex.org/I1299303238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012134128","display_name":"Patrizia Popoli","orcid":"https://orcid.org/0000-0002-9064-0639","observed_orcids":["https://orcid.org/0000-0002-9064-0639"]},"institutions":[{"id":"https://openalex.org/I27897274","display_name":"Istituto Superiore di Sanit\u00e0","ror":"https://ror.org/02hssy432","country_code":"IT","type":"government","lineage":["https://openalex.org/I27897274"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Patrizia Popoli","raw_affiliation_strings":["Istituto Superiore di Sanit\u00e0, Italian National Institute of Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Superiore di Sanit\u00e0, Italian National Institute of Health","institution_ids":["https://openalex.org/I27897274"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110935158","display_name":"Steven R. Goldberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Steven Goldberg","raw_affiliation_strings":["Preclinical Pharmacology Section"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Preclinical Pharmacology Section","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048458525","display_name":"Kjell Fux\u00e9","orcid":"https://orcid.org/0000-0001-8491-4288","observed_orcids":["https://orcid.org/0000-0001-8491-4288"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Kjell Fuxe","raw_affiliation_strings":["Karolinska Institutet"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karolinska Institutet","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013842852","display_name":"Carme Llu\u0131\u0301s","orcid":"https://orcid.org/0000-0003-2869-6882","observed_orcids":["https://orcid.org/0000-0003-2869-6882"]},"institutions":[{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carme Lluis","raw_affiliation_strings":["Universitat de Barcelona (University of Barcelona)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universitat de Barcelona (University of Barcelona)","institution_ids":["https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043879414","display_name":"Rafael Franco","orcid":"https://orcid.org/0000-0003-2549-4919","observed_orcids":["https://orcid.org/0000-0003-2549-4919"]},"institutions":[{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Rafael Franco","raw_affiliation_strings":["Universitat de Barcelona (University of Barcelona)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universitat de Barcelona (University of Barcelona)","institution_ids":["https://openalex.org/I71999127"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109940290","display_name":"Luigi F. Agnati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I122346577","display_name":"University of Modena and Reggio Emilia","ror":"https://ror.org/02d4c4y02","country_code":"IT","type":"education","lineage":["https://openalex.org/I122346577"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Luigi Agnati","raw_affiliation_strings":["Universit\u00e0 degli Studi di Modena e Reggio Emilia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e0 degli Studi di Modena e Reggio Emilia","institution_ids":["https://openalex.org/I122346577"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.9626,"has_fulltext":false,"cited_by_count":29,"citation_normalized_percentile":{"value":0.85571521,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":97},"biblio":{"volume":"3","issue":"1","first_page":"1","last_page":"26"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.7289999723434448,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.11240000277757645,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.08820000290870667,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mglu5-receptor","display_name":"mGlu5 receptor","score":0.968999981880188},{"id":"https://openalex.org/keywords/adenosine-a2a-receptor","display_name":"adenosine A2A receptor","score":0.9509999752044678},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":1.0},{"id":"https://openalex.org/keywords/heteromeric-receptors","display_name":"heteromeric receptors","score":0.925000011920929},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.8109999895095825},{"id":"https://openalex.org/keywords/dendritic-spines","display_name":"dendritic spines","score":0.8690000176429749},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.7720000147819519},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.9919999837875366},{"id":"https://openalex.org/keywords/drug-addiction","display_name":"drug addiction","score":0.9929999709129333},{"id":"https://openalex.org/keywords/opioid-reward","display_name":"opioid reward","score":0.6050000190734863},{"id":"https://openalex.org/keywords/psychostimulants","display_name":"psychostimulants","score":0.8730000257492065},{"id":"https://openalex.org/keywords/antipsychotic-effects","display_name":"antipsychotic effects","score":0.75},{"id":"https://openalex.org/keywords/basal-ganglia-diseases","display_name":"basal ganglia disorders","score":0.7639999985694885},{"id":"https://openalex.org/keywords/drug-therapy","display_name":"pharmacotherapy","score":0.47699999809265137}],"concepts":[{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.6687408089637756},{"id":"https://openalex.org/C2778491162","wikidata":"https://www.wikidata.org/wiki/Q3063865","display_name":"Adenosine A2A receptor","level":5,"score":0.6615138649940491},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.5891453623771667},{"id":"https://openalex.org/C2779177108","wikidata":"https://www.wikidata.org/wiki/Q18356742","display_name":"GABAergic","level":3,"score":0.5704711079597473},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.47729671001434326},{"id":"https://openalex.org/C135285700","wikidata":"https://www.wikidata.org/wiki/Q38173","display_name":"G protein-coupled receptor","level":3,"score":0.468363881111145},{"id":"https://openalex.org/C61174792","wikidata":"https://www.wikidata.org/wiki/Q420510","display_name":"Glutamate receptor","level":3,"score":0.46496444940567017},{"id":"https://openalex.org/C41653306","wikidata":"https://www.wikidata.org/wiki/Q6589190","display_name":"Metabotropic glutamate receptor 5","level":5,"score":0.4598345160484314},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.43566516041755676},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.4302852749824524},{"id":"https://openalex.org/C16587737","wikidata":"https://www.wikidata.org/wiki/Q4682273","display_name":"Adenosine A2B receptor","level":5,"score":0.42993441224098206},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.38752034306526184},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3710796535015106},{"id":"https://openalex.org/C67907053","wikidata":"https://www.wikidata.org/wiki/Q356147","display_name":"Adenosine receptor","level":4,"score":0.3655090928077698},{"id":"https://openalex.org/C49051014","wikidata":"https://www.wikidata.org/wiki/Q2033959","display_name":"Metabotropic glutamate receptor","level":4,"score":0.18085834383964539},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.15998154878616333},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10871204733848572},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2174/1568015033357779","doi":"https://doi.org/10.2174/1568015033357779","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1568015033357779","pdf_url":null,"source":{"id":"https://openalex.org/S2765063124","display_name":"Central Nervous System Agents in Medicinal Chemistry","issn_l":"1568-0150","issn":["1568-0150","1871-5249","1875-6158","1875-6166"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","medline","norway-1","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry-Central Nervous System Agents","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8048999905586243}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2030152049","https://openalex.org/W2087137226","https://openalex.org/W1980620322","https://openalex.org/W2343248697","https://openalex.org/W1989467245","https://openalex.org/W2101166473","https://openalex.org/W2068153172","https://openalex.org/W2110093932","https://openalex.org/W1996149423","https://openalex.org/W2056083897"],"abstract_inverted_index":{"There":[0],"is":[1,65,123],"growing":[2],"evidence":[3],"for":[4,127,136,180,185],"the":[5,67,93,96,99,112,128,137,148,156,162,169],"existence":[6],"of":[7,37,50,59,70,88,95,98,114,131,140,144,158,164,174],"not":[8],"only":[9],"homomeric,":[10],"but":[11],"also":[12],"functional":[13],"heteromeric":[14,205],"receptor":[15,33,39,42,63,90,145,150,166,206],"complexes,":[16,207],"particularly":[17],"involving":[18,48],"G":[19],"protein":[20],"coupled":[21],"receptors":[22],"(GPCRs).":[23],"These":[24],"include":[25],"adenosine":[26,30,198],"A2A-dopamine":[27],"D2":[28,196],"and":[29,54,61,78,121,133,135,153,177,191],"A2A-glutamate":[31],"mGlu5":[32,202],"complexes.":[34],"The":[35,56,103,142],"role":[36,87,110],"these":[38,175],"complexes":[40,64,146],"in":[41,66,79,92,111,168,188],"function":[43,97],"seems":[44],"to":[45,155],"be":[46],"multiple,":[47],"hetero-modulation":[49],"ligand":[51],"recognition,":[52],"signalling":[53],"trafficking.":[55],"preferential":[57],"localization":[58],"A2A-D2":[60],"A2A-mGlu5":[62],"dendritic":[68],"spines":[69],"striatopallidal":[71,100,104],"GABAergic":[72,101,105],"neurons.":[73,102],"Results":[74],"obtained":[75],"from":[76],"behavioral":[77],"vivo":[80],"microdialysis":[81],"experiments":[82],"have":[83],"shown":[84],"an":[85],"important":[86],"mGlu5-A2A-D2":[89,165],"interactions":[91,167],"modulation":[94],"neurons":[106],"play":[107],"a":[108,124,181],"key":[109],"pathophysiology":[113],"basal":[115],"ganglia":[116],"disorders,":[117],"like":[118],"Parkinsons":[119,208],"disease,":[120,209],"it":[122],"common":[125],"pathway":[126],"rewarding":[129],"effects":[130,139],"opiates":[132],"psychostimulants":[134],"antipsychotic":[138],"neuroleptics.":[141],"formation":[143],"modifies":[147],"single":[149],"transducing":[151],"characteristics":[152],"leads":[154],"appearance":[157],"\u201cemergent":[159],"properties\u201d.":[160],"Thus,":[161],"study":[163],"striatum":[170],"reveals":[171],"new":[172,182],"properties":[173],"GPCRs":[176],"gives":[178],"indications":[179],"rational":[183],"approach":[184],"drug":[186,192,211],"therapy":[187],"neuro-psychiatric":[189],"disorders":[190],"addiction.":[193],"Keywords:":[194],"Dopamine":[195],"receptor,":[197,200,203],"A2A":[199],"glutamate":[201],"striatum,":[204],"schizophrenia,":[210],"addiction":[212]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}